James Parslow - Interim CEO and CFO at Xenetic Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO and CFO
Stock Symbol
XBIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Parslow since 11/6/2023

Holdings reported by James Parslow for Xenetic Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options 20K Jun 18, 2024 Direct Common Stock

Transactions reported by James Parslow for Xenetic Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.